Shelby Dane Menie, LPN in Gore, OK - Licensed Practical Nurse

Shelby Dane Menie, LPN is a Licensed Practical Nurse based in Gore, Oklahoma. Shelby Dane Menie is licensed to practice in Oklahoma (license number L0065513) and her current practice location is 300 W 5th St Lot 19, Gore, Oklahoma. She can be reached at her office (for appointments etc.) via phone at (918) 348-4384.

NPI number for Shelby Dane Menie is 1013787134 and her current mailing address is 711 S Muskogee Ave, Tahlequah, Oklahoma. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1013787134.

Contact Information

	Shelby Dane Menie, LPN
	300 W 5th St Lot 19, Gore, OK 74435-5377
	(918) 348-4384
	Not Available

Provider's Profile

Full Name	Shelby Dane Menie
Gender	Female
Speciality	Licensed Practical Nurse
Location	300 W 5th St Lot 19, Gore, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1013787134
Provider Enumeration Date: 01/09/2024
Last Update Date: 01/09/2024

Medical Identifiers

Medical identifiers for Shelby Dane Menie such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013787134	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
164W00000X	Licensed Practical Nurse	L0065513 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shelby Dane Menie is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Shelby Dane Menie, LPN 711 S Muskogee Ave, Tahlequah, OK 74464-4717 Ph: (918) 348-4384	Shelby Dane Menie, LPN 300 W 5th St Lot 19, Gore, OK 74435-5377 Ph: (918) 348-4384

News Archive

Atrium to focus on metabolic syndrome, nutrition research

Atrium Innovations Inc., a recognized leading developer, manufacturer and marketer of professionally endorsed, science-based dietary supplements for the health and nutrition industry, today announced a multi-year commitment to nutrition research and to a comprehensive program focusing on metabolic syndrome.

EHSI to sign definitive agreement with OceanBASIS

Emerging Healthcare Solutions, Inc. announced today that it is moving forward with negotiations toward a profit participation agreement with OceanBASIS, a German company specializing in stem-cell and marine-collagen technologies and products.

Bio-Path 2011 net loss increases to $2,363,344

Bio-Path Holdings, Inc., a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the year ended December 31, 2011.

Recent clinical trials in patients with ALBP show that SOMA 250 mg reduces disability

A recent analysis of two pivotal clinical trials in patients with acute low back pain (ALBP) who were treated with SOMA® (carisoprodol) 250 mg showed significantly improved functionality and reduced disability after three days of treatment, as measured by the Roland-Morris Disability Questionnaire (RMDQ).

Shelby Dane Menie, LPN - Licensed Practical Nurse in Gore, OK